Neo
This from the last half year
"The company launched Bronchitol in Europe in June 2012. The sales for the period ended 31 December reflects the
additional contribution by Bronchitol. Overall gross margin was 64% of sales for the half-year ended 31 December 2012
(2011: 62%), reflecting a change in sales mix between products (Aridol vs Bronchitol) and region mix."
On a mix of aridol and bronchitol on as yet very low sales.
notice received, page-19
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
